DailyIQ
Last updated 3 minutes ago

BWXT·BWX Technologies Inc.

$.
-. (-.%)
After Hours
High
$175.98
Open
$174.52
Market Cap
15.85B
52W High
$241.82
Low
$170.16
P. Close
$173.68
P/E
46.01
52W Low
$136.18
Fwd P/E
169.37
DailyIQ Est.
$246.77
Technical Score (1D)
14
SELL
News Sentiment
-
NO DATA
BWXT’s most recent earnings report, released 160 hours ago, showed a stronger-than‑expected quarter and an upward revision of its 2026 guidance, underscoring the company’s continued ability to beat analyst estimates. The beat, driven by robust government contracts and a growing commercial nuclear backlog, signals that the firm’s revenue mix is shifting toward higher‑margin commercial work, which could sustain earnings momentum into the next quarter. In parallel, the company completed its acquisition of Precision Components Group 237 hours ago, adding heavy‑manufacturing capacity for complex, heat‑transfer components that are critical for U.S. nuclear life‑extension and new‑build projects; this expansion should enhance supply‑chain resilience and open new revenue streams. The acquisition also prompted BWXT’s removal from several Russell 1000 Defensive‑style indexes 201 hours ago, a move that reflects a market perception shift from a purely defense‑heavy profile to a more diversified growth outlook. Following the index shift, several research firms upgraded the stock, citing the broadened product portfolio and the potential for cost synergies, which has attracted fresh buy calls from Deutsche Bank and Seaport Research 207 hours ago. Despite these positive signals, Argus Research lowered its price target to $206 200 hours ago, citing concerns over competitive pressures in the nuclear materials sector and slower revenue growth expectations, which introduces a valuation uncertainty that traders should monitor. The next key event is BWXT’s Q2 2026 earnings release scheduled for August 3, which will provide updated guidance on revenue, operating margins, and the progress of the Precision Components integration. Traders should also watch for any new contract awards or backlog updates that could confirm the commercial expansion narrative, as well as potential index rebalancing flows that might affect liquidity and beta.
Earnings Summary
BWXT Technologies, Inc. (BWXT) is a global provider of specialized nuclear components and services, focusing on the design, manufacture, and servicing of reactors, fuel, and related equipment for government and commercial customers, including the U.S. Navy and commercial nuclear power plants. Operating within the industrials sector and the aerospace & defense industry, the company’s diversified customer base spans naval, research, and commercial nuclear applications, positioning it to benefit from both defense spending and commercial nuclear growth. In its most recent reporting period, BWXT delivered earnings per share of $1.08 in Q4 2025, surpassing the $0.88396 estimate, and generated $885.84 million in revenue, beating the $837.47 million forecast; the following quarter’s results continued the trend with an EPS of $1.12 versus a $0.9443 estimate and revenue of $860.22 million versus a $855.46 million projection, underscoring a consistent pattern of earnings beats over the last four quarters. Historically, BWXT has maintained a streak of outperforming analyst expectations, with EPS growth outpacing estimates and revenue growth remaining positive despite a slight dip in the most recent quarter, indicating a resilient earnings trajectory. Recent news highlights the completion of the Precision Components Group acquisition, which expands BWXT’s heavy‑manufacturing footprint and adds complex component production for commercial nuclear life‑extension and new‑build projects, and the long‑term supply agreement with ATI that secures key materials for the U.S. Naval Nuclear Propulsion Program; these developments have prompted index rebalancing and fresh buy calls, reinforcing a more diversified growth outlook. Investors should watch the upcoming Q2 2026 filing for updated guidance on revenue, operating margins, and the progress of the Precision Components integration, as well as any new contract awards or backlog updates that could confirm the commercial expansion narrative, and monitor the impact of the ATI supply agreement on production capacity and cost structure, as these factors will likely shape the next earnings narrative.

EPS

EstBeatMiss
$0.71$0.83$0.94$1.06$1.17Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.04 - -
Q1'26$0.94$1.12+18.6%
Q4'25$0.88$1.08+22.2%
Q3'25$0.87$1.00+14.3%
Q2'25$0.79$1.02+28.7%
Q1'25$0.76$0.91+19.0%

Revenue

EstBeatMiss
$646M$724M$801M$879M$956MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$921M - -
Q1'26$855M$860M+0.6%
Q4'25$837M$886M+5.8%
Q3'25 - $866M -
Q2'25 - $764M -
Q1'25 - $682M -

Market Data

BWXT Stock Snapshot

BWXT is currently trading at $176.01, giving BWX Technologies Inc. a market cap of 15.85B and a P/E ratio of 46.0. Today's range spans $170.16–$175.98, with shares opening at $174.52 and moving up $2.33 (1.3%) from the prior close. DailyIQ's technical score sits at 14/100 (SELL).

Over the past year BWXT has traded between $136.18 and $241.82 - the current price is +29.2% off the 52-week low and -27.2% from the high. 23 analysts cover the stock with a Buy consensus and a mean 12-month target of $238.79 (range $200.00–$290.00), implying upside of +35.7%.

BWXT is showing a SELL signal (14/100) with neutral sentiment (-/100). Price: $176.01 (in the lower half of its 52-week range within $136.18–$241.82). (P/E: 46.0) At 15.85B in Industrials market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.

Analyst coverage for BWXT becomes a double-edged factor in a SELL phase: at 15.85B in Industrials market cap, active coverage is high enough that downgrade risk is real and impactful. The 14/100 technical reading and neutral sentiment (-/100) at $176.01 (in the lower half of its 52-week range) place the stock in the zone where one or two high-profile estimate cuts can convert a grinding decline into a sharper re-rating — the $136.18–$241.82 range establishes where that repricing lands.